Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Return on Sales [ROS] (2019 - 2024)

Updated

Revolution Medicines (RVMD) reported Return on Sales [ROS] of -88031.94% for Q3 2024, down 86622.17 percentage points from -1409.77% a year earlier and down 7070.62 percentage points from the prior quarter.

Analysis

Revolution Medicines (RVMD) Return on Sales [ROS] (2019 - 2024) Analysis & Trends

For FY2023, Revolution Medicines posted Return on Sales [ROS] of -4207.12%, down 3477.11 percentage points from FY2022.

  • Return on Sales [ROS] has declined for four consecutive years, with a five-year change of -4007.13 percentage points (FY2018 to FY2023).
  • By year, Return on Sales [ROS] came in at -730.01% in FY2022 (-90.31 pp), -639.70% in FY2021 (-382.16 pp), -257.54% in FY2020 (-149.39 pp) and -108.15% in FY2019 (+91.84 pp).
  • The Q3 2024 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q1 2019.
  • Year over year, Return on Sales [ROS] has now declined in each of the last four quarters, with an average year-over-year change of -25134.11 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q3 2022 (a gain of 2548.13 percentage points); the low point was Q3 2024 (a drop of 86622.17 percentage points).
  • Per Business Quant data, the three quarters before Q3 2024 came in at -80961.32% (Q2 2024), -12108.78% (Q1 2024) and -24256.47% (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 28.21%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 37.86%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 32.97%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 20.57%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -133.21%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 28.37%
10 Revolution Medicines 37.70 Bn 27.90 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -88,031.94%
Jun 30, 2024 -80,961.32%
Mar 31, 2024 -12,108.78%
Dec 31, 2023 -24,256.47%
Sep 30, 2023 -1,409.77%
Jun 30, 2023 -2,845.11%
Mar 31, 2023 -1,071.53%
Dec 31, 2022 -402.52%
Sep 30, 2022 -2,280.48%
Jun 30, 2022 -681.10%
Mar 31, 2022 -764.70%
Dec 31, 2021 -559.33%
Sep 30, 2021 -4,828.61%
Jun 30, 2021 -512.01%
Mar 31, 2021 -369.13%
Dec 31, 2020 -389.44%
Sep 30, 2020 -217.61%
Jun 30, 2020 -279.14%
Mar 31, 2020 -182.59%
Dec 31, 2019 -161.85%
API Access

Revolution Medicines Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RVMD&period=max&api_key=YOUR_API_KEY